296 related articles for article (PubMed ID: 25789847)
41. MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer.
Peurala H; Greco D; Heikkinen T; Kaur S; Bartkova J; Jamshidi M; Aittomäki K; Heikkilä P; Bartek J; Blomqvist C; Bützow R; Nevanlinna H
PLoS One; 2011; 6(11):e26122. PubMed ID: 22102859
[TBL] [Abstract][Full Text] [Related]
42. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres.
Ji Q; Hao X; Meng Y; Zhang M; Desano J; Fan D; Xu L
BMC Cancer; 2008 Sep; 8():266. PubMed ID: 18803879
[TBL] [Abstract][Full Text] [Related]
43. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling.
Cover CM; Hsieh SJ; Tran SH; Hallden G; Kim GS; Bjeldanes LF; Firestone GL
J Biol Chem; 1998 Feb; 273(7):3838-47. PubMed ID: 9461564
[TBL] [Abstract][Full Text] [Related]
44. Expression of p53 in the effects of artesunate on induction of apoptosis and inhibition of proliferation in rat primary hepatic stellate cells.
Longxi P; Buwu F; Yuan W; Sinan G
PLoS One; 2011; 6(10):e26500. PubMed ID: 22053192
[TBL] [Abstract][Full Text] [Related]
45. Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics.
Chekhun VF; Lukianova NY; Borikun TV; Zadvorny TV; Mokhir A
Exp Oncol; 2017 Mar; 39(1):25-29. PubMed ID: 28361857
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
47. MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4.
Feng T; Xu D; Tu C; Li W; Ning Y; Ding J; Wang S; Yuan L; Xu N; Qian K; Wang Y; Qi C
Tumour Biol; 2015 Aug; 36(8):5987-97. PubMed ID: 25731732
[TBL] [Abstract][Full Text] [Related]
48. Potential using of microRNA-34A in combination with paclitaxel in colorectal cancer cells.
Soltani-Sedeh H; Irani S; Mirfakhraie R; Soleimani M
J Cancer Res Ther; 2019; 15(1):32-37. PubMed ID: 30880751
[TBL] [Abstract][Full Text] [Related]
49. Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling.
Tran KQ; Tin AS; Firestone GL
Anticancer Drugs; 2014 Mar; 25(3):270-81. PubMed ID: 24296733
[TBL] [Abstract][Full Text] [Related]
50. Suppressive effect of exogenous miR-16 and miR-34a on tumorigenesis of breast cancer cells.
Haghi M; Taha MF; Javeri A
J Cell Biochem; 2019 Aug; 120(8):13342-13353. PubMed ID: 30916815
[TBL] [Abstract][Full Text] [Related]
51. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells.
Fan S; Meng Q; Auborn K; Carter T; Rosen EM
Br J Cancer; 2006 Feb; 94(3):407-26. PubMed ID: 16434996
[TBL] [Abstract][Full Text] [Related]
52. Molecular characterization of the cyclin-dependent protein kinase 6 in whitefish (Coregonus lavaretus) and its potential interplay with miR-34a.
Łakomiak A; Brzuzan P; Jakimiuk E; Florczyk M; Woźny M
Gene; 2019 May; 699():115-124. PubMed ID: 30858134
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53.
Abdolvahabi Z; Nourbakhsh M; Hosseinkhani S; Hesari Z; Alipour M; Jafarzadeh M; Ghorbanhosseini SS; Seiri P; Yousefi Z; Yarahmadi S; Golpour P
J Cell Biochem; 2019 Jun; 120(6):9356-9368. PubMed ID: 30520099
[TBL] [Abstract][Full Text] [Related]
54. Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells.
Caruso JA; Campana R; Wei C; Su CH; Hanks AM; Bornmann WG; Keyomarsi K
Cell Cycle; 2014; 13(16):2587-99. PubMed ID: 25486199
[TBL] [Abstract][Full Text] [Related]
55. Alternative mechanisms of miR-34a regulation in cancer.
Slabáková E; Culig Z; Remšík J; Souček K
Cell Death Dis; 2017 Oct; 8(10):e3100. PubMed ID: 29022903
[TBL] [Abstract][Full Text] [Related]
56. Curcumin Promoted miR-34a Expression and Suppressed Proliferation of Gastric Cancer Cells.
Sun C; Zhang S; Liu C; Liu X
Cancer Biother Radiopharm; 2019 Dec; 34(10):634-641. PubMed ID: 31539270
[No Abstract] [Full Text] [Related]
57. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
[TBL] [Abstract][Full Text] [Related]
58. Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.
Wang X; Zhu J
Thorac Cancer; 2018 Jun; 9(6):676-683. PubMed ID: 29697201
[TBL] [Abstract][Full Text] [Related]
59. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
[TBL] [Abstract][Full Text] [Related]
60. Indole-3-carbinol disrupts estrogen receptor-alpha dependent expression of insulin-like growth factor-1 receptor and insulin receptor substrate-1 and proliferation of human breast cancer cells.
Marconett CN; Singhal AK; Sundar SN; Firestone GL
Mol Cell Endocrinol; 2012 Nov; 363(1-2):74-84. PubMed ID: 22835548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
